Department of Aged Care, The Northern Hospital, Epping, Victoria, Australia.
Am J Cardiol. 2010 Sep 15;106(6):865-72. doi: 10.1016/j.amjcard.2010.05.012.
After emergency orthopedic-geriatric surgery, cardiac complications are an important cause of morbidity and mortality. The utility of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) for the prediction of cardiac complications and mortality was evaluated. NT-pro-BNP was tested pre- and postoperatively in 89 patients >60 years of age. They were followed for 2 years for cardiac complications (defined as acute myocardial infarction, congestive cardiac failure, atrial fibrillation or major arrhythmia) or death. Receiver operating characteristic curves were constructed to determine the optimal discriminatory level for cardiac events and death using NT-pro-BNP. Twenty-three patients (25.8%) sustained an in-hospital postoperative cardiac complication. Total all-cause mortality was 3 of 89 (3.4%) in hospital, 21 of 89 (23.6%) at 1 year, and 27 of 89 (30.3%) at 2 years. Median preoperative and postoperative NT-pro-BNP levels were higher in patients who had an in-hospital cardiac event compared to those without (387 vs 1,969 pg/ml, p <0.001; and 676 vs 7,052 pg/ml, p <0.001 respectively). The optimal discriminatory level for preoperative NT-pro-BNP was 842 pg/ml and that for postoperative NT-pro-BNP was 1,401 pg/ml for the prediction of in-hospital cardiac events and 1- and 2-year mortality. Preoperative NT-pro-BNP >/=842 pg/ml (odds ratio 11.6, 95% confidence interval 2.1 to 65.0, p = 0.005) was an independent predictor of in-hospital cardiac complications using multivariate analysis and pre- and postoperative NT-pro-BNP levels were independent predictors of 2-year cardiovascular events. Patients who had preoperative NT-pro-BNP >/=842 pg/ml or postoperative NT-pro-BNP >/=1,401 pg/ml had significantly worse survival using log-rank testing (p <0.001) and these variables independently predicted 2-year mortality. In conclusion, increase pre- and postoperative NT-pro-BNP levels are independent predictors of in-hospital cardiac events and 1- and 2-year mortality in older patients undergoing emergency orthopedic surgery.
在紧急骨科-老年医学手术后,心脏并发症是发病率和死亡率的重要原因。评估了 N 端脑利钠肽前体(NT-pro-BNP)对心脏并发症和死亡率预测的作用。在 89 名年龄大于 60 岁的患者中,在术前和术后检测了 NT-pro-BNP。他们在 2 年内随访,以确定心脏并发症(定义为急性心肌梗死、充血性心力衰竭、心房颤动或主要心律失常)或死亡。使用 NT-pro-BNP 构建受试者工作特征曲线以确定心脏事件和死亡的最佳鉴别水平。23 名患者(25.8%)在住院期间发生术后心脏并发症。总全因死亡率为 89 例中的 3 例(3.4%)住院,89 例中的 21 例(23.6%)1 年,89 例中的 27 例(30.3%)2 年。与无院内心脏事件的患者相比,发生院内心脏事件的患者术前和术后 NT-pro-BNP 中位数水平更高(387 比 1969pg/ml,p <0.001;676 比 7052pg/ml,p <0.001)。术前 NT-pro-BNP 的最佳鉴别水平为 842pg/ml,术后 NT-pro-BNP 的最佳鉴别水平为 1401pg/ml,用于预测院内心脏事件和 1 年及 2 年死亡率。多变量分析显示,术前 NT-pro-BNP>/=842pg/ml(比值比 11.6,95%置信区间 2.1 至 65.0,p = 0.005)是院内心脏并发症的独立预测因子,术前和术后 NT-pro-BNP 水平是 2 年心血管事件的独立预测因子。使用对数秩检验,术前 NT-pro-BNP>/=842pg/ml 或术后 NT-pro-BNP>/=1401pg/ml 的患者生存明显较差(p<0.001),这些变量独立预测了 2 年死亡率。总之,术前和术后 NT-pro-BNP 水平升高是老年患者接受紧急骨科手术后院内心脏事件和 1 年及 2 年死亡率的独立预测因子。